More from Dividend.com
Referenced Stocks

MKM downgrades Pfizer; “Neutral” Rating (PFE)

By Dividend.com November 27, 2012, 08:57:54 AM EDT

MKM Partners reported on Tuesday that they have downgraded global biopharmaceutical company, Pfizer Inc.( PFE ).

The firm announced that they have downgraded the company from a "Buy" to "Neutral." Analysts believe that PFE has few near-term catalysts and a weak pipeline.

Pfizer shares were mostly flat during premarket trading Tuesday. The stock is up 13.17% YTD.

The Bottom Line
Shares of Pfizer ( PFE ) have a 3.59% dividend yield, based on last night's closing stock price of $24.49. We have been recommending shares of Pfizer ( PFE ) since Mar.2, 2012, when the stock was trading at $21.49.

Pfizer Inc.( PFE ) is a "Recommended" dividend stock at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: PFE



Latest News Video

Pope Tells Church to Adapt
Pope Tells Church to Adapt          


From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%